22403409|t|The protein phosphatase PP2A/Balpha binds to the microtubule-associated proteins Tau and MAP2 at a motif also recognized by the kinase Fyn: implications for tauopathies.
22403409|a|The predominant brain microtubule-associated proteins MAP2 and tau play a critical role in microtubule cytoskeletal organization and function. We have previously reported that PP2A/Balpha, a major protein phosphatase 2A (PP2A) holoenzyme, binds to and dephosphorylates tau, and regulates microtubule stability. Here, we provide evidence that MAP2 co-purifies with and is dephosphorylated by endogenous PP2A/Balpha in bovine gray matter. It co-localizes with PP2A/Balpha in immature and mature human neuronal cell bodies. PP2A co-immunoprecipitates with and directly interacts with MAP2. Using in vitro binding assays, we show that PP2A/Balpha binds to MAP2c isoforms through a region encompassing the microtubule-binding domain and upstream proline-rich region. Tau and MAP2 compete for binding to and dephosphorylation by PP2A/Balpha. Remarkably, the protein-tyrosine kinase Fyn, which binds to the proline-rich RTPPKSP motif conserved in both MAP2 and tau, inhibits the interaction of PP2A/Balpha with either tau or MAP2c. The corresponding synthetic RTPPKSP peptide, but not the phosphorylated RpTPPKSP version, competes with Tau and MAP2c for binding to PP2A/Balpha. Significantly, down-regulation of PP2A/Balpha and deregulation of Fyn-Tau protein interactions have been linked to enhanced tau phosphorylation in Alzheimer disease. Together, our results suggest that PP2A/Balpha is part of segregated MAP2 and tau signaling scaffolds that can coordinate the action of key kinases and phosphatases involved in modulating neuronal plasticity. Deregulation of these compartmentalized multifunctional protein complexes is likely to contribute to tau deregulation, microtubule disruption, and altered signaling in tauopathies.
22403409	81	84	Tau	Gene	4137
22403409	89	93	MAP2	Gene	4133
22403409	135	138	Fyn	Gene	2534
22403409	157	168	tauopathies	Disease	MESH:D024801
22403409	224	228	MAP2	Gene	4133
22403409	233	236	tau	Gene	4137
22403409	439	442	tau	Gene	4137
22403409	512	516	MAP2	Gene	281294
22403409	587	593	bovine	Species	9913
22403409	663	668	human	Species	9606
22403409	751	755	MAP2	Gene	4133
22403409	822	827	MAP2c	Gene	4133
22403409	932	935	Tau	Gene	4137
22403409	940	944	MAP2	Gene	4133
22403409	1022	1045	protein-tyrosine kinase	Gene	2046
22403409	1046	1049	Fyn	Gene	2534
22403409	1115	1119	MAP2	Gene	4133
22403409	1124	1127	tau	Gene	4137
22403409	1181	1184	tau	Gene	4137
22403409	1188	1193	MAP2c	Gene	4133
22403409	1299	1302	Tau	Gene	4137
22403409	1307	1312	MAP2c	Gene	4133
22403409	1407	1410	Fyn	Gene	2534
22403409	1411	1414	Tau	Gene	4137
22403409	1465	1468	tau	Gene	4137
22403409	1488	1505	Alzheimer disease	Disease	MESH:D000544
22403409	1576	1580	MAP2	Gene	4133
22403409	1585	1588	tau	Gene	4137
22403409	1817	1820	tau	Gene	4137
22403409	1835	1857	microtubule disruption	Disease	MESH:D019958
22403409	1884	1895	tauopathies	Disease	MESH:D024801
22403409	Association	MESH:D000544	4137
22403409	Association	2534	4137
22403409	Association	2046	4133
22403409	Association	MESH:D024801	2534
22403409	Association	MESH:D019958	4137
22403409	Association	2046	4137
22403409	Association	MESH:D000544	2534
22403409	Association	2534	4133
22403409	Association	MESH:D024801	4133

